[6] Brothers-in-law Greg Conigliaro and Barry Cadden established Ameridose to be a large manufacturer of prescription medications for use in hospitals.
The original location of the company's plant was in Framingham, Massachusetts next to its sister-companies New England Compounding Center and Medical Sales Management.
Due to pressure from the state and the U.S. Food and Drug Administration (FDA) because of growing concern of their association with NECC, the company recalled all of its products and shut down operations in Novemeber 2012.
[12] She also claimed that she witnessed company supervisors attempting to cover up their tracks for taking shortcuts when they learned that the FDA was going to inspect their facilities.
Additionally, The Tennessean reported that between 2007 and 2013, majority shareholders Carla and Doug Conigliaro received a total of $120 million from New England Compounding Center and Ameridose.